In 2023, HUMANCONTACT partnered with Novo Nordisk to lead the national launch campaign for Rybelsus, a breakthrough GLP-1 medication, under the “Ask Your Doctor” platform. The campaign aimed to introduce Rybelsus to Canadian audiences while educating them on its benefits and encouraging conversations with healthcare providers.
HC not only developed the campaign strategy but also led the end-to-end production and execution of all the creative elements. A multi-channel media plan included prominent national broadcast TV, out-of-home (OOH) and digital out-of-home (DOOH) placements, print, and digital advertising. Special care was taken to ensure wide coverage across pan-Canadian and bilingual locations, extending the campaign’s reach to diverse demographic groups.
Creative executions were adapted across screens and formats, from stadium billboards and escalator panels to tablet, mobile, and streaming audio ads. The result was a cohesive, high visibility launch that generated significant brand awareness and share of voice for Rybelsus in Canada’s competitive pharmaceutical market.
ClientNovo NordiskServicesCampaign Strategy, Broadcast Production, OOH & DOOH, Digital & Print Advertising, Media PlanningYear2023
